Insider · CIK 0002037191

Kentaro Suzuki

officer

Files at NAUT (Nautilus Biotechnology, Inc.). First filing Nov 10, 2025, latest Nov 10, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

1 / 0

$5,960 bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NAUT: Nautilus Biotechnology, Inc.

NAUTOct 9, 2026 · close 2.25

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
23Weak	NAUTbuy Nautilus Biotechnology, Inc.	$5,960 4,000 shares	-	-	Nov 10, 2025

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Nov 6, 2025	NAUT Nautilus Biotechnology, Inc.	POpen-market purchase Common Stock	+4,000	$1.49	$5,960	4,000	Nov 10, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.